Brochure
4 Oct 2023
Cyclolab Dexolve Presentation
PDF 2.4 MB
Content provided by our supplier
CYCLOLAB Ltd.
-
HU
-
2019On CPHI since
-
4Certificates
-
50 - 99Employees
Company types
Primary activities
Other Content from CYCLOLAB Ltd. (2)
-
News Company introduction – Cyclolab Cyclodextrin Research and Development Ltd
CycloLab Cyclodextrin Research and Development Ltd. is a private SME with the focus on cyclodextrin research and development for over 30 years. We are working in the fields of pharmaceutical, cosmetic and food industry, agrochemical, environmental and analytical applications of cyclodextrins. -
News Remdesivir with Dexolve: fight against COVID-19
CycloLab, being involved in the fight, manufactures the critical excipient: sulfobutyl-ether-BCD (SBECD, Dexolve™) that enables Remdesivir to work. The unexpected and sudden outbreak along with the quick spread of the coronavirus-disease and rapid increase of the cases draw a sudden need for Dexolve.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance